__timestamp | Dr. Reddy's Laboratories Limited | Perrigo Company plc |
---|---|---|
Wednesday, January 1, 2014 | 12402000000 | 152500000 |
Thursday, January 1, 2015 | 17449000000 | 187800000 |
Friday, January 1, 2016 | 17834000000 | 184000000 |
Sunday, January 1, 2017 | 19551000000 | 167700000 |
Monday, January 1, 2018 | 18265000000 | 218600000 |
Tuesday, January 1, 2019 | 15607000000 | 187400000 |
Wednesday, January 1, 2020 | 15410000000 | 177700000 |
Friday, January 1, 2021 | 16541000000 | 122000000 |
Saturday, January 1, 2022 | 17482000000 | 123100000 |
Sunday, January 1, 2023 | 19381000000 | 122500000 |
Monday, January 1, 2024 | 22873000000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, research and development (R&D) investment is a key driver of innovation and growth. Over the past decade, Dr. Reddy's Laboratories Limited has consistently outpaced Perrigo Company plc in R&D spending. From 2014 to 2023, Dr. Reddy's increased its R&D investment by approximately 84%, peaking in 2023. In contrast, Perrigo's R&D expenses remained relatively stable, with a slight decline observed in recent years.
Dr. Reddy's commitment to innovation is evident, with its R&D expenses reaching nearly 20 times that of Perrigo's in 2023. This significant investment underscores Dr. Reddy's strategic focus on developing new products and enhancing existing ones. Meanwhile, Perrigo's steady R&D spending suggests a more conservative approach, potentially focusing on optimizing current offerings. The data for 2024 is incomplete, highlighting the need for ongoing analysis to understand future trends.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Perrigo Company plc
R&D Spending Showdown: Zoetis Inc. vs Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for argenx SE and Perrigo Company plc
Comparing Innovation Spending: Biogen Inc. and Perrigo Company plc
Research and Development Expenses Breakdown: Dr. Reddy's Laboratories Limited vs Apellis Pharmaceuticals, Inc.
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Agios Pharmaceuticals, Inc.
R&D Insights: How Dr. Reddy's Laboratories Limited and BioCryst Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Perrigo Company plc
Blueprint Medicines Corporation vs Perrigo Company plc: Strategic Focus on R&D Spending
Alkermes plc or Perrigo Company plc: Who Invests More in Innovation?
Research and Development Investment: Verona Pharma plc vs Perrigo Company plc
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs Perrigo Company plc